Allison Makovec

Employment

• University of Minnesota Research Development Manager
  2024 - 2025

Education

• University of Kansas Medical Center MD/ PhD
  2025 - Present
• University of Minnesota BS - Anthropology
  2020 - 2024
• University of Minnesota BA -Biology, Society, and Environment
  2020 - 2024

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
  Clinical Cancer Research 2026 DOI: 10.1158/1078-0432.CCR-26-0322
  +Save
• Data from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
  2026 DOI: 10.1158/1078-0432.c.8630799
  +Save
• Supplemental Table 1 from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
  2026 DOI: 10.1158/1078-0432.33143493
  +Save
• Supplemental Tables 2-10 from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
  2026 DOI: 10.1158/1078-0432.33143490
  +Save
• Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes
  Prostate Cancer and Prostatic Diseases 2025 DOI: 10.1038/s41391-025-01009-z
  +Save
• CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.
  NPJ precision oncology 2025 DOI: 10.1038/s41698-025-01051-z
  +Save
• HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers
  Nikitha Vobugari, Allison Makovec, Samuel Kellen +17 more
  International Journal of Molecular Sciences 2025 DOI: 10.3390/ijms26125720
  +Save
• The Influence of the Germline HSD3B1 Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer
  Samuel Kellen, Allison Makovec, Carly D. Miller +12 more
  Cancers 2025 DOI: 10.3390/cancers17081270
  +Save
• Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes
  Prostate Cancer and Prostatic Diseases 2025 DOI: 10.1038/s41391-024-00797-0
  +Save
• CREB5 as an essential transcription and tumorigenic regulator in basal-like breast and prostate cancer.
  American Society of Clinical Oncology 2024 DOI: 10.1200/jco.2024.42.16_suppl.1107
  +Save
• Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies
  Carly D. Miller, John R. Lozada, Nicholas A. Zorko +20 more
  Cancer Research Communications 2024 DOI: 10.1158/2767-9764.CRC-23-0546
  +Save
• Mechanisms of endocrine resistance to letrozole, fulvestrant, and palbociclib are associated with increased sensitivity to hexyl-cuban-1-yl biguanide inhibitors of CYP3A4 mediated epoxyeicosatrienoic acid biosynthesis
  American Association for Cancer Research 2024 DOI: 10.1158/1538-7445.am2024-lb334
  +Save
• Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2023 DOI: 10.1158/1078-0432.ccr-22-3394
  +Save
• Clinical and molecular features of ATM and BRCA2 mutations in metastatic prostate cancer.
  Journal of Clinical Oncology 2023 DOI: 10.1200/jco.2023.41.6_suppl.245
  +Save